StockData
Embecta Corp. logo

Embecta Corp. (EMBC) stock

EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3079% below fair value
$6.43−0.10 (-1.53%)

Close on Nov 12, 2026Market cap $364.32MP/E 4.4Yield 9.33%

Embecta profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Embecta's profit margin for the twelve months ending Jun 30, 2026 was 8.6%. For fiscal 2025 it was 8.8%, against 7.0% the year before. The highest annual figure on record is 39.4% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Sep 30, 20258.8%+1.9
FY2024Sep 30, 20247.0%+0.7
FY2023Sep 30, 20236.3%−13.5
FY2022Sep 30, 202219.8%−15.8
FY2021Sep 30, 202135.6%−3.8
FY2020Sep 30, 202039.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ2 2026Jun 30, 20267.8%−7.6
Q2 FY2026CQ1 2026Mar 31, 2026-1.8%−10.9
Q1 FY2026CQ4 2025Dec 31, 202516.9%+16.9
Q4 FY2025CQ3 2025Sep 30, 202510.0%+4.9
Q3 FY2025CQ2 2025Jun 30, 202515.4%+10.0
Q2 FY2025CQ1 2025Mar 31, 20259.1%−1.0
Q1 FY2025CQ4 2024Dec 31, 20240.0%−7.2
Q4 FY2024CQ3 2024Sep 30, 20245.1%+3.0
Q3 FY2024CQ2 2024Jun 30, 20245.4%+0.1
Q2 FY2024CQ1 2024Mar 31, 202410.1%+5.0
Q1 FY2024CQ4 2023Dec 31, 20237.2%−5.5
Q4 FY2023CQ3 2023Sep 30, 20232.1%+8.4
Q3 FY2023CQ2 2023Jun 30, 20235.3%−16.1
Q2 FY2023CQ1 2023Mar 31, 20235.1%−23.9
Q1 FY2023CQ4 2022Dec 31, 202212.8%−21.4
Q4 FY2022CQ3 2022Sep 30, 2022-6.3%−38.5
Q3 FY2022CQ2 2022Jun 30, 202221.4%−14.1
Q2 FY2022CQ1 2022Mar 31, 202229.0%−9.0
Q1 FY2022CQ4 2021Dec 31, 202134.2%−2.8
Q4 FY2021CQ3 2021Sep 30, 202132.2%–
Q3 FY2021CQ2 2021Jun 30, 202135.5%–
Q2 FY2021CQ1 2021Mar 31, 202138.0%–
Q1 FY2021CQ4 2020Dec 31, 202036.9%–

More Embecta figures

See a number that looks wrong?